Literature DB >> 16162026

Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials.

Andrea Manca1, Stephen Palmer.   

Abstract

BACKGROUND: Missing data are potentially an extensive problem in cost-effectiveness analyses conducted alongside randomised clinical trials, where prospective collection of both resource use and health outcome information is required. There are several possible reasons for the presence of incomplete records, and the validity of the analysis in the presence of data with missing values is dependent upon the mechanism generating the missing data phenomenon. In the past, the most commonly used methods for analysing datasets with incomplete observations were relatively ad hoc (e.g. case deletion, mean imputation) and suffered from potential limitations. Recently, several alternative and more sophisticated approaches (e.g. multiple imputation) have been proposed that attempt to correct the flaws of the simple imputation methods.
OBJECTIVES: The objectives are to provide a concise and accessible description of the quantitative methods most commonly used in trial-based cost-effectiveness analysis for handling missing data, and also to demonstrate the potential impact of these alternative approaches on the cost-effectiveness results reported in two case studies.
METHODS: Data from two recently conducted, trial-based economic evaluations are used to explore the sensitivity of the study results to the technique used to deal with incomplete observations. A statistical framework for representing the uncertainty in the alternative methods is outlined using an approach based on net benefits and cost-effectiveness acceptability curves.
RESULTS: The case studies demonstrate the potential importance of the approach used to handle missing data. Although the analytical strategy did not appear to alter the results of one of the studies, the other case study showed that that the results of the cost-effectiveness analysis were sensitive to both the decision to impute and also the imputation strategy adopted.
CONCLUSIONS: Analysts should be more explicit in reporting the analytical strategies applied in the presence of missing data. The use of a multiple imputation approach is recommended in the majority of cases, so as to adequately reflect the uncertainty in the study results due to the presence of missing data.

Entities:  

Mesh:

Year:  2005        PMID: 16162026     DOI: 10.2165/00148365-200504020-00001

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  33 in total

1.  Guidelines for conducting and reporting economic evaluation of fall prevention strategies.

Authors:  J C Davis; M C Robertson; T Comans; P A Scuffham
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

2.  A randomised controlled trial of acupuncture care for persistent low back pain: cost effectiveness analysis.

Authors:  J Ratcliffe; K J Thomas; H MacPherson; J Brazier
Journal:  BMJ       Date:  2006-09-15

3.  Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters.

Authors:  Jeffrey S Hoch; Carolyn S Dewa
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis.

Authors:  J C Davis; C A Marra; M C Robertson; K M Khan; M Najafzadeh; M C Ashe; T Liu-Ambrose
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

5.  Sustained economic benefits of resistance training in community-dwelling senior women.

Authors:  Jennifer C Davis; Carlo A Marra; M Clare Robertson; Mehdi Najafzadeh; Teresa Liu-Ambrose
Journal:  J Am Geriatr Soc       Date:  2011-06-30       Impact factor: 5.562

6.  The economic burden of complications during percutaneous coronary intervention.

Authors:  Kurt M Jacobson; Kirsten Hall Long; Erin K McMurtry; James M Naessens; Charanjit S Rihal
Journal:  Qual Saf Health Care       Date:  2007-04

7.  Surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: the UK FROST three-arm RCT.

Authors:  Stephen Brealey; Matthew Northgraves; Lucksy Kottam; Ada Keding; Belen Corbacho; Lorna Goodchild; Cynthia Srikesavan; Saleema Rex; Charalambos P Charalambous; Nigel Hanchard; Alison Armstrong; Andrew Brooksbank; Andrew Carr; Cushla Cooper; Joseph Dias; Iona Donnelly; Catherine Hewitt; Sarah E Lamb; Catriona McDaid; Gerry Richardson; Sara Rodgers; Emma Sharp; Sally Spencer; David Torgerson; Francine Toye; Amar Rangan
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

8.  Effects of simultaneous prenatal exposures to organophosphate and synthetic pyrethroid insecticides on infant neurodevelopment at three months of age.

Authors:  Kyle R Fluegge; Marcia Nishioka; J R Wilkins
Journal:  J Environ Toxicol Public Health       Date:  2016-05-19

9.  SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions.

Authors:  J C Davis; T Liu-Ambrose; K M Khan; M C Robertson; C A Marra
Journal:  Osteoporos Int       Date:  2011-09-10       Impact factor: 4.507

10.  A cost-utility comparison of four first-line medications in painful diabetic neuropathy.

Authors:  Alec B O'Connor; Katia Noyes; Robert G Holloway
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.